4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
about
4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
4-aminopyridyl-based lead comp ...... f Trypanosoma cruzi infection.
@en
4-aminopyridyl-based lead comp ...... f Trypanosoma cruzi infection.
@nl
type
label
4-aminopyridyl-based lead comp ...... f Trypanosoma cruzi infection.
@en
4-aminopyridyl-based lead comp ...... f Trypanosoma cruzi infection.
@nl
prefLabel
4-aminopyridyl-based lead comp ...... f Trypanosoma cruzi infection.
@en
4-aminopyridyl-based lead comp ...... f Trypanosoma cruzi infection.
@nl
P2093
P2860
P50
P1476
4-aminopyridyl-based lead comp ...... f Trypanosoma cruzi infection.
@en
P2093
Alanderson Nogueira
Brian Suzuki
Claudia Magalhaes Calvet
Jair Lage Siqueira-Neto
James H McKerrow
Jun Yong Choi
Ken Hirata
Liliane Batista de Mesquita
Marcelo Meuser-Batista
Mirian Claudia de Souza Pereira
P2860
P304
P356
10.1371/JOURNAL.PNTD.0006132
P407
P577
2017-12-27T00:00:00Z